| Bioactivity | cis-Clopidogrel-MP derivative (Clopidogrel-MP-AM) is a 3’-methoxyacetophenone derivative of Clopidogrel active metabolite[1]. Clopidogrel is an orally active platelet inhibitor that targets P2Y12 receptor[2]. |
| Name | cis-Clopidogrel-MP derivative |
| CAS | 1122047-98-6 |
| Formula | C25H26ClNO6S |
| Molar Mass | 504.00 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Makoto Takahashi, et al. Quantitative determination of clopidogrel active metabolite in human plasma by LC-MS/MS. harm Biomed Anal. 2008 Dec 1;48(4):1219-24. [2]. Zongyu Zheng, et al. Clopidogrel Reduces Fibronectin Accumulation and Improves Diabetes-Induced Renal Fibrosis. Int J Biol Sci. 2019 Jan. |
cis-Clopidogrel-MP derivative
CAS: 1122047-98-6 F: C25H26ClNO6S W: 504.00
cis-Clopidogrel-MP derivative (Clopidogrel-MP-AM) is a 3’-methoxyacetophenone derivative of Clopidogrel active metaboli
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.